GE Healthcare partners to create manufacturing suite for gene therapies

By Ben Hargreaves

- Last updated on GMT

(Image: Getty/Bulat Silvia)
(Image: Getty/Bulat Silvia)

Related tags Ge healthcare FlexFactory Germfree Gene therapy

GE Healthcare teams up with Germfree to create a fully integrated, expandable manufacturing solution that is geared towards the development of ‘emerging biotherapeutics’.

GE Healthcare will provide its proprietary design work for the facility, alongside its FlexFactory single-use biomanufacturing platform, while Germfree will provide process-ready cleanroom facilities to round out the offering.

A spokesperson for GE Healthcare told us that the solution will include a biosafety level 2 (BSL-2) environment design, which is suitable to be paired with the company’s biomanufacturing platform for gene therapies.

Together, a platform will be developed that will increase ‘capacity and capability’ in the gene therapy market, the companies stated.

A spokesperson for GE Healthcare told us that the technology can be scaled up to meet customers’ needs: “This good manufacturing practice compliant solution will allow manufacturers of biotherapeutics to expand their capacity (scale-out/scale up) through clinical and commercial manufacturing. The modular design will allow customers to expand by adding new modules as needed.”

The development comes as larger companies in the gene therapy have taken the step to build out their own gene therapy manufacturing capabilities.

Iovance recently increased its clinical and commercial capabilities​ with a $75m (€67.3m) investment and Pfizer recently chose to do the same ahead of the start of a Phase III clinical trial​ for its Duchenne muscular dystrophy gene therapy candidate.

GE Healthcare and Germfree’s manufacturing offering comes amid a wider regenerative medicine market that is predicted to grow at compound annual growth rate (CAGR) of 23.8%​.

The spokesperson told us the technology would be available by the end of October.

Related news

Show more

Related products

show more

Trends in Biopharmaceutical Raw Material Selection

Trends in Biopharmaceutical Raw Material Selection

Actylis – The Partner of Choice | 31-Jan-2023 | Business Advice

Join us as our in-house experts, along with Cecile Bellamy from Pfizer, discuss current and future trends in biopharmaceutical raw material selection.

eBook: mRNA prospects and scale-up solutions

eBook: mRNA prospects and scale-up solutions

Thermo Fisher Scientific - Biosciences | 01-Jan-2023 | Insight Guide

This mRNA eBook was created by Thermo Fisher Scientific, in collaboration with Genetic Engineering & Biotechnology News (GEN), to provide you with...

Liposomal and Nanoparticle Technology

Liposomal and Nanoparticle Technology

Pfizer CentreOne | 18-Nov-2022 | Technical / White Paper

Medical science is continuously searching for better ways to administer drugs into the body and to maximize the therapeutic effectiveness of the drugs...

Related suppliers

Follow us


View more